↓ Skip to main content

Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials

Overview of attention for article published in BMC Cancer, January 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials
Published in
BMC Cancer, January 2022
DOI 10.1186/s12885-022-09227-7
Pubmed ID
Authors

Michael J. Grayling, Martina McMenamin, Robert Chandler, Rakesh Heer, James M. S. Wason

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 20%
Other 1 10%
Student > Master 1 10%
Unknown 6 60%
Readers by discipline Count As %
Medicine and Dentistry 2 20%
Arts and Humanities 1 10%
Immunology and Microbiology 1 10%
Business, Management and Accounting 1 10%
Unknown 5 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 March 2022.
All research outputs
#14,689,038
of 24,753,534 outputs
Outputs from BMC Cancer
#3,216
of 8,767 outputs
Outputs of similar age
#228,066
of 512,508 outputs
Outputs of similar age from BMC Cancer
#53
of 214 outputs
Altmetric has tracked 24,753,534 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,767 research outputs from this source. They receive a mean Attention Score of 4.6. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 512,508 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 214 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.